eMC Medicine Guides  
The electronic Medicines Compendium (eMC) contains information about UK licensed medicines.
go to eMC homepage
Search for:  
  Advanced Search

Warner Chilcott UK Limited
1 The Heights, Brooklands, Weybridge, KT12 0NY
Telephone: +44 (0)1932 82 9600
Fax: +44 (0)1932 82 1644
WWW: http://www.wcrx.com
Medical Information Direct Line: +44 (0)800 0328 701
Medical Information e-mail: medcomukir@wcrx.com
Medical Information Fax: +44 (0)1932 824 775

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 11/11/2011
PIL Actonel 30mg Film Coated Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 11/11/2011 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
Updated on 28/10/2011 and displayed until 11/11/2011
Reasons for adding or updating:
  • Change to side-effects
Updated on 07/10/2010 and displayed until 28/10/2011
Reasons for adding or updating:
  • Change/addition of instructions for reconstitution and/ or administration
  • Change to date of revision
Updated on 17/05/2010 and displayed until 07/10/2010
Reasons for adding or updating:
  • Change of manufacturer
  • Change of licence holder
  • Change to date of revision
Updated on 19/02/2010 and displayed until 17/05/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
Updated on 29/07/2009 and displayed until 19/02/2010
Reasons for adding or updating:
  • Change in co-marketing arrangement
Updated on 09/01/2009 and displayed until 29/07/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
Updated on 13/08/2008 and displayed until 09/01/2009
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 17/01/2008 and displayed until 13/08/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 11/08/2006 and displayed until 17/01/2008
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 01/08/2006 and displayed until 11/08/2006
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 01/08/2006 and displayed until 01/08/2006
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 04/03/2005 and displayed until 01/08/2006
Reasons for adding or updating:
  • Change to dosage and administration
Updated on 14/05/2003 and displayed until 04/03/2005
Reasons for adding or updating:
  • Update to PIL
  • PIL Retired pending re-submission
Updated on 14/06/2000 and displayed until 14/05/2003
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
  risedronate sodium